Psychemedics Corporation (PMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
PMD POWR Grades
- PMD scores best on the Growth dimension, with a Growth rank ahead of 0% of US stocks.
- The strongest trend for PMD is in Stability, which has been heading down over the past 117 days.
- PMD's current lowest rank is in the Growth metric (where it is better than 0% of US stocks).
PMD Stock Summary
- Psychemedics Corp's market capitalization of $41,579,062 is ahead of just 7.18% of US-listed equities.
- Over the past twelve months, PMD has reported earnings growth of -426.82%, putting it ahead of just 4.74% of US stocks in our set.
- Revenue growth over the past 12 months for Psychemedics Corp comes in at -44.8%, a number that bests merely 7.89% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Psychemedics Corp, a group of peers worth examining would be YCBD, LBRT, MDRX, INTZ, and RNGR.
- Visit PMD's SEC page to see the company's official filings. To visit the company's web site, go to www.psychemedics.com.
PMD Stock Price Chart Interactive Chart >
PMD Price/Volume Stats
|Current price||$7.51||52-week high||$8.36|
|Prev. close||$7.29||52-week low||$3.58|
|Day high||$7.70||Avg. volume||32,446|
|50-day MA||$7.01||Dividend yield||N/A|
|200-day MA||$5.82||Market Cap||41.58M|
Psychemedics Corporation (PMD) Company Bio
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The companys tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company was founded in 1985 and is based in Acton, Massachusetts.
PMD Latest News Stream
|Loading, please wait...|
PMD Latest Social Stream
View Full PMD Social Stream
Latest PMD News From Around the Web
Below are the latest news stories about Psychemedics Corp that investors may wish to consider to help them evaluate PMD as an investment opportunity.
ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2021. The Company’s revenue for the quarter ended March 31, 2021 was $5.7 million versus $7.5 million for the quarter ended March 31, 2020, a decrease of 24%. Net income for the quarter ended March 31, 2021 was $0.1 million or $0.01 per diluted share, versus net loss of $0.2 million or ($0.03) per diluted share, for the comparable period last year, an increase of $0.04 per diluted share. Raymond C. Kubacki, Chairman and Chief Executive Officer, stated: "We continued to see improvement in total revenues, month-to-month and quarter-to-quarter, since the COVID-19 shutdow...
GAINERS: Cannabics Pharmaceuticals (OTC: CNBX ) shares closed up 10.92% at $0.29 MGC Pharmaceuticals (OTC: MGCLF ) shares closed up 7.78% at $0.05 Psychemedics (NASDAQ: PMD ) shares closed up 3.9% at $6.92 Invictus MD Strategies (OTC: IVITF ) shares closed up 3.66% at $0.04 Alcanna (OTC: LQSIF ) shares closed up 3.54% at $6.21 Genetic Technologies (NASDAQ: GENE ) shares closed up 3.34% at $4.33 SOL Global Investments (OTC: SOLCF ) shares closed up 3.06% at $3.70 LOSERS: Zelira Therapeutics (OTC: ZLDAF ) shares closed down 11.11% at … Full story available on Benzinga.com
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA ) rose 44.4% to $10.73 in pre-market trading after the company, and EMC Pharma, announced an exclusive partnership to expand commercial channels of the Microcyn-based Rx dermatology and eye care products nationwide. AeroCentury Corp. (NYSE: ACY ) rose 38.3% to $ 4.91 in pre-market trading. The company recently reported that it filed a petition for a Chapter 11 reorganization. P&F Industries, Inc. (NASDAQ: PFIN ) shares rose 27.5% to $8.39 in pre-market trading after gaining over 9% on Wednesday. The company recently reported results for the year ended December 31, 2020. Psychemedics Corporation (NASDAQ: PMD ) rose 25.8% to $7.80 in pre-market trading. The company recently reported a Q4 loss. Jaguar Health, Inc. (NASDAQ: JAGX ) rose 17.8...
GAINERS: Primo Nutraceuticals (PINK: BUGVF ) shares closed up 1.09% at $3.81 CLS Holdings USA (OTCQB: CLSH ) shares closed up 3.31% at $0.25 Psychemedics (NASDAQ: PMD ) shares closed up 2.21% at $7.18 Vireo Health Intl (OTCQX: VREOF ) shares closed up 2.15% at $3.32 LOSERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed down 20.95% at $0.05 Empower Clinics (PINK: EPWCF ) shares closed down 18.48% at $0.60 48North Cannabis (PINK: NCNNF ) shares closed down 16.71% at $0.20 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed down 15.32% at $1.88 General Cannabis (OTCQB: CANN ) shares closed down 13.64% at $0.95 Hollister Biosciences (PINK: HSTRF ) shares closed down 13.21% at $0.26 Heritage Cannabis Holding (OTCQX: HERTF ) shares closed down 12.62% at $0.13 Full story available on Benzi...
GAINERS: Psychemedics (NASDAQ: PMD ) shares closed up 34.3% at $7.44 World Acceptance (NASDAQ: WRLD ) shares closed up 13.09% at $125.19 High Tide (OTCQB: HITIF ) shares closed up 11.74% at $0.53 OrganiGram Holdings (NASDAQ: OGI ) shares closed up 11.66% at $1.82 Origin Agritech (NASDAQ: SEED ) shares closed up 10.81% at $21.22 Tilray (NASDAQ: TLRY ) shares closed up 10.74% at $19.03 Cannabix Technologies (PINK: BLOZF ) shares closed up 10.57% at $1.41 EnWave (PINK: NWVCF ) shares closed up 9.49% at $1.10 cbdMd, Inc. (AMEX: YCBD) shares closed up 8.14% at $3.72 HEXO (NYSE: Full story available on Benzinga.com
PMD Price Returns